SCHEMBL22139237

SCHEMBL22139237

COc1ccc(-c2cnc3c(Nc4ccc(C(=O)N5CCN(C(C)=O)CC5)c(C)c4)nccn23)c(Cl)c1F

nearest known ligand 0.48

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
▸ PTK6 Q13882 16/20 0.48
▸ AURKB Q96GD4 4/20 0.41
▸ IGF1R P08069 3/20 0.39
▸ LCK P06239 5/20 0.39
▸ FGFR2 P21802 1/20 0.38
▸ FGFR3 P22607 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22139158 0.93 PTK6 (0.46) PTK6AURKBIGF1RLCK
SCHEMBL24910529 0.92 PTK6 (0.46) PTK6AURKBLCK
SCHEMBL22139090 0.92 PTK6 (0.58) PTK6AURKBLCK
SCHEMBL22124049 0.92 PTK6 (0.46) PTK6AURKBIGF1RLCK
Hydrochloric Acid SCHEMBL30172053 0.91 PTK6 (0.57) PTK6AURKBLCK
SCHEMBL22139138 0.91 PTK6 (0.45) PTK6AURKBIGF1RLCKFGFR3
SCHEMBL22139132 0.90 PTK6 (0.45) PTK6AURKBLCK
SCHEMBL22123982 0.90 PTK6 (0.44) PTK6AURKBLCK
SCHEMBL22124309 0.90 PTK6 (0.51) PTK6AURKBLCK
SCHEMBL30177684 0.90 PTK6 (0.51) PTK6AURKBLCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020127075-A1 IMIDAZOPYRAZINE DERIVATIVES AS ANTIBACTERIALS F. HOFFMANN-LA ROCHE AG (CH) 2020-06-25 — — WO disclosed
WO-2020126954-A1 NOVEL IMIDAZOPYRAZINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2020-06-25 — — WO disclosed
WO-2020126952-A1 IMIDAZOPYRAZINE DERIVATIVES AS ANTIBACTERIAL AGENTS F. HOFFMANN-LA ROCHE AG (CH) 2020-06-25 — — WO disclosed
WO-2020126956-A1 IMIDAZOPYRAZINE DERIVATIVES AS ANTIBACTERIAL AGENTS F. HOFFMANN-LA ROCHE AG (CH) 2020-06-25 — — WO disclosed
Send feedback